| Date | Speaker | Title | Time starts | Duration |
| November 2015 | Chris Kosmidis | Isavuconazole: a new antifungal drug | 0’00’00secs | 0’36’40secs |
| Graham Atherton | Patients and carers disucssion | 0’36’40secs | end | |
| Led by Graham Atherton | Entire meeting (alternate version) |
We had to switch off the discussion with patients after Chris & Graham’s introduction ending at 36min 40sec as the group had to proceed privately. The slides discussed give a good deal of the information we talked about so are well worth reading once the talking has stopped.
Resources mentioned:
Share this post
Latest News posts
The Host, its Microbiome and their Aspergillosis.
August 13, 2020
COVID-19 and Lung Disease
June 30, 2020
Fungal spore and air quality forecasts
June 8, 2020
The New York Times on the dangers of mould
June 7, 2020
Extraordinary images of Aspergillus restrictus
June 4, 2020
Can I have ABPA without asthma?
May 29, 2020
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video